Leukemia Fellowship

General Information
The Leukemia Fellowship Program accepts applications for potential positions August 1, 2023, through October 31, 2023, with the program accepting a limited number of new fellows each year. Initially, a one-year commitment to the Program is required. Fellows in their first year may be considered for an additional year at their request.

The Leukemia Fellowship is non-standard and commences July 1 through June 30 and is recognized by the Texas Medical Board as an approved fellowship program. The program is affiliated with The University of Texas MD Anderson Cancer Center’s Hematology/Oncology Fellowship which is accredited by ACGME.

For general inquires please send email to leuktrain@mdanderson.org.

Information for GME Applicants

The Program achieves its goals through a combination of inpatient and outpatient clinical experiences.  The ACGME core competencies and milestones are achieved through a required set of rotations, a didactic curriculum and elective rotations designed to broaden the base of knowledge. The Fellowship complements the hands on training with an even broader range of conferences that are available through national and international hematology and medical oncology organizations.  Fellows are involved in clinical research and are encouraged to develop a research program of his/her own and to compete for national presentations and awards. 

The recent achievements of our Program describes an undeniable understanding just how valuable it is to provide in-depth clinical training in the diagnosis and management of leukemia and related malignant disorders (MDS, MPN), and to provide clinical and research training in acute leukemia. 

During the first year of fellowship is designed to orient the trainee to the diseases and treatments commonly encountered in leukemia.  This intense, hands-on training includes outpatient clinics where the fellow serves as the primary oncologist for the patient, and benefits from close precepting.  Fellows are expected to learn about each case from all available resources, including literature and faculty experts.  During this time, the fellow also rotates through leukemia inpatient wards to gain focused exposure to specific disease types.

During the optional second year of training, the fellow continues to expand his or her general clinical education through outpatient clinic, inpatient consults and specialty projects.  In addition to the clinical responsibilities, fellows begin to focus on a narrow subspecialty, both clinically and in research.

• Individuals applying for admissions into the Leukemia Fellowship Program must hold either a M.D./D.O. degree or its foreign equivalent along with a valid certificate from the Educational Commission for Foreign Medical Graduates (ECFMG).
• Applicants must have successfully completed and passed the USMLE Step 1 and Step 2 CK exams.
• Applicants must be able to obtain and maintain a Texas Training Permit, required by the Texas State Board of Medical Examiners, and maintain appropriate visa status.
• Individuals who are interested in applying must have completed three (3) years of internal medicine training by the start of the program which begins July 1.

The Leukemia Fellowship Program accepts applications for positions from August 1, 2023 through October 31, 2023.

The deadline for submission of applications for the 2024-2025 Academic Year (July 1, 2024-June 30, 2025) is October 31, 2023. 
All application contingencies must be finalized prior to the deadline. Incomplete applications and late inquiries are not accepted.

• To initiate the application process, please submit a current CV to leuktrain@mdanderson.org
• Positions are available on a highly-competitive basis.
• Applications are accepted through the DISCOVER application system.
• The application checklist provides information on all required documents to upload into DISCOVER and/or to request from other entities.
• Interviews will tentatively be conducted upon completion of all application requirements, and, if chosen to move forward in the selection process.

Class of 2023

Fellow | Next Assignment | Location
Tareq Abuasab, M.D. | Assistant Professor - Hematology & Oncology | Baylor College of Medicine | Houston, TX
Alexandre Bazinet, M.D. | Assistant Professor - Leukemia | MD Anderson Cancer Center | Houston, TX
Rodrick Babakhanlou, M.D. | Consultant | The Royal Marsden Hospital | London, United Kingdom
Sai Prasad Desikan, M.D. | Clinical Fellow - Nephrology | Ohio State University | Columbus, OH
Faustine Ong, M.D. | Clinical Fellow | Moffitt Cancer Center | Tampa, FL
Jayastu Senapati, M.D. | Assistant Professor - Leukemia | MD Anderson Cancer Center | Houston, TX

Class of 2022

Fellow | Next Assignment | Location
Daniel Rivera, M.D. |  UT Health Houston Program (Hematopathology Residency) | Houston, TX
Fadi Haddad, M.D. | MD Anderson - Assistant Professor - Leukemia | Houston, Texas
Kunhwa Kim, M.D. | MD Anderson – DoCM Hematology/Oncology Fellow | Houston, Texas
Sangeetha Venugopal, M.D. | Sylvester Cancer Center, University of Miami (Assistant Professor) | Miami, FL
 

Class of 2021

Fellow | Next Assignment | Location
Yasmin Alwash, M.D. |  Mount Sinai Medical Center | Miami, Florida
Danielle Hammond, M.D. | MD Anderson Cancer Center | Houston, Texas
Shehab Mohamed, M.D. |  National Center of Cancer Care and Research | Doha, Qatar
Kiyomi Morita, M.D. Ph.D. |  AstraZeneca | Tokyo, Japan
Jorge Ramos-Perez, M.D. | City of Hope Comprehensive Cancer Center | Duarte, CA
Maria Siddiqui, M.D. | Baylor College of Medicine | Houston, Texas

Class of 2020

Fellow | Next Assignment | Location
Hycienth Ahaneku, M.D., Dr.PH. |  Beaumont Health System Royal |  Oak, Michigan
Ahmad Saleh T Alotaibi, M.D. | King Faisal Specialist Hospital | Riyadh, Saudi Arabia
Veronica Guerra, M.D. | Mount Sinai Medical Center  |  Miami, Florida
Arrvind Raghunath, MBBS | Texas Tech University Health Sciences Center | Lubbock, Texas
Bachra Samra, M.D. | Presbyterian Healthcare System | Albuquerque, New Mexico
Omar Shahin, MBBCh | King Hussein Cancer Center | Amnan, Jordan
Guillaume Richard-Carpentier, M.D. | Queen's University Kingston | Ontario, Canada

Class of 2019

Fellow | Next Assignment | Location
Iman Abou Dalle, M.D. |  American University of Beirut - Lebanon | Beirut, Lebanon
Mansour Alfayez, M.D. |  King Fahad Medical City | Riyadh, Saudi Arabia
Yamil Michelen Alvarez, M.D. | Stony Brook University Hospital |  Stony Brook, New York
Darwin Roman, M.D. | University of Southern California | Los Angeles, California
Mahran Shoukier, M.D. | MD Anderson Cancer Center - Gen. Internal Med. (Fellow) | Houston, Texas
Mahesh Swaminathan, MBBS | Roswell Park Comprehensive Cancer Center | Buffalo, New York
Eran Tallis, M.D. | Baylor College of Medicine | Houston, Texas
Fevzi Firat Yilnaz, M.D. | MD Anderson Cancer Center - Stem Cell (Fellow) | Houston, Texas